AI assistant
AROA BIOSURGERY LIMITED — AGM Information 2022
Jun 15, 2022
64426_rns_2022-06-15_9899a180-d064-4266-a0ae-a0f2f041295e.pdf
AGM Information
Open in viewerOpens in your device viewer
ASX ANNOUNCEMENT/MEDIA RELEASE 16 JUNE 2022
==> picture [113 x 52] intentionally omitted <==
ANNU AL GENERAL M EETIN G DATE AND DI RECTOR NOMI NATION CLOSIN G D AT E
In accordance with ASX Listing Rule 3.13.1, Aroa Biosurgery Limited (ASX: ARX) (“Company”), advises that its next Annual General Meeting (“AGM”) will be held on Wednesday, 10 August 2022. An election of directors will be held at this AGM pursuant to ASX Listing Rule 14.5. Details of the Directors to be elected will be included in the forthcoming Notice of AGM.
The Closing Date for receipt of nominations for the position of Director is Wednesday, 22 June 2022. Any nominations must be received in writing no later than 5:00 pm NZST on this date at the Company’s Registered Office.
The Company notes that the deadline for nominations for the position of Director is separate to voting on Director elections. Details of the Directors to be elected will be provided in the Company’s Notice of AGM in due course.
< ENDS >
Authorised on behalf of the Aroa Biosurgery Board of Directors by Brian Ward, CEO.
About AROA™
Aroa Biosurgery is a soft-tissue regeneration company committed to ‘unlocking regenerative healing for everybody’. We develop, manufacture, sell and distribute medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Our products are developed from a proprietary AROA ECM™ technology platform, a novel extracellular matrix biomaterial derived from ovine (sheep) forestomach. AROA’s products have been used in more than four and a half million procedures to date, with distribution into our key market of the United States via our direct sales force and our partner TELA Bio. Founded in 2008, AROA is headquartered in Auckland, New Zealand and is listed on the Australian Securities Exchange (ASX:ARX). www.aroabio.com
Contacts
Investor Relations Simon Hinsley Investor Relations [email protected] + 61 401 809 653
Media Australia Matthew Wright [email protected] +61 451 896 420
New Zealand Piet De Jong [email protected] +64 21 812 766
==> picture [273 x 34] intentionally omitted <==
AROA BIOSURGERY LIMITED ARBN 638 867 473 NZCN 1980577 64 Richard Pearse Drive, Auckland 2022, New Zealand AROABIO.COM